SEC Filings | Jasper Therapeutics, Inc

Filing date	Description	Form	Filing Group	View
May 12, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	0001213900-23-039021.pdf 0001213900-23-039021.rtf 0001213900-23-039021.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 5, 2023	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	424B5	Registration Statements	0001213900-23-036926.pdf 0001213900-23-036926.rtf View HTML
May 5, 2023	EFFECT	EFFECT	Other	9999999995-23-001326.pdf 9999999995-23-001326.rtf 9999999995-23-001326.xls View HTML
May 3, 2023	CORRESP	CORRESP	Other	0001213900-23-036051.pdf 0001213900-23-036051.rtf 0001213900-23-036051.xls View HTML
May 2, 2023	UPLOAD	UPLOAD	Other	0000000000-23-004531.pdf 0000000000-23-004531.rtf View HTML
April 28, 2023	Simplified registration form	S-3	Registration Statements	0001213900-23-033846.pdf 0001213900-23-033846.rtf 0001213900-23-033846.xls View HTML
April 21, 2023	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	Proxy Filings	0001213900-23-031673.pdf 0001213900-23-031673.rtf 0001213900-23-031673.xls View HTML
April 21, 2023	Additional proxy soliciting materials - definitive	DEFA14A	Proxy Filings	0001213900-23-031676.pdf 0001213900-23-031676.rtf 0001213900-23-031676.xls View HTML
April 21, 2023	An annual report to security holders	ARS	Annual Filings	0001213900-23-031678.pdf 0001213900-23-031678.rtf View HTML
April 14, 2023	Report of unscheduled material events or corporate event	8-K	Current Reports	0001213900-23-029872.pdf 0001213900-23-029872.rtf 0001213900-23-029872.xls EX-101.DEF - XBRL DEFINITION FILE View HTML

Data provided by Kaleidoscope.